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Abstract
Background b-cell hyperplasia has been implicated in the aetiology of post Roux-en-Y gastric bypass hyperinsulinaemic
hypoglycaemia, but the pathogenesis of this condition is still unclear.
Case report We report a case of a 52-year-old man with post-Roux-en-Y gastric bypass hyperinsulinaemic
hypoglycaemia who underwent distal pancreatectomy to alleviate his symptoms. Pancreatic histopathology showed
chronic pancreatitis with a corresponding loss of exocrine tissue and islet retention. Amyloid deposition was found in
pancreatic islets. These features are more typically associated with Type 2 diabetes.
Discussion This case highlights the potential multifactorial pathogenesis of symptomatic hypoglycaemia after
Roux-en-Y gastric bypass.
Diabet. Med. 31, e29–e32 (2014)
Introduction
Hyperinsulinaemic hypoglycaemia is a rare complication of
Roux-en-Y gastric bypass. b-cell hyperplasia has been impli-
cated and ascribed to excessive glucagon-like peptide-1 secre-
tion [1–3]; however, this hypothesis has been subject to debate,
as other groups have shown similar histological findings in
patients without hypoglycaemia [4]. In the present report we
present a patient with this condition who was found to have
pancreatic histology typically associated with Type 2 diabetes.
Materials and methods
Histopathological studies were carried out at the Department
of Pathology, University of Michigan. Haematoxylin and
eosin staining was performed on pancreatic sections that had
been formalin fixed and paraffin embedded. For immunohis-
tochemistry, pancreatic sections were incubated with either
rabbit polyclonal antiglucagon or rabbit polyclonal
anti-insulin antibodies from Ventana Medical Systems (Basel,
Switzerland).
Case report
A 52-year-old man was evaluated for recurrent episodes of
hypoglycaemia for 6 months. He reported multiple episodes
of hypoglycaemia during the night, in the early morning and
> 4 hours after meals. He had had insulin-treated Type 2
diabetes mellitus for 10 years until 2003, when he underwent
a Roux-en-Y gastric bypass and total gastrectomy (see
below) for morbid obesity and diabetes. Shortly after the
surgery, insulin was withdrawn as a result of improvement in
glycaemic control and he subsequently lost 50 kg in weight.
Since 2005 he has experienced recurrent episodes of fasting
hypoglycaemia (1.6–2.2 mmol/l or 30–40 mg/dl), accompa-
nied by neuroglycopenic symptoms (lethargy and disorienta-
tion) and aborted with glucose intake (Whipple’s triad). To
avoid hypoglycaemia, he had been eating frequently and had
gained weight. A therapeutic trial with a combination of
somatostatin analogue and diazoxide failed to alleviate his
symptoms. a-glucosidase inhibitor was not given because of
the patient’s chronic gastrointestinal symptoms and a
calcium blocker was not given because of his low blood
pressure [5].
The patient’s medical history was noteworthy for gas-
tro-oesophageal reflux disease treated with Nissen’s fundopli-
cation in 2000 and pantoprazole. The patient did not develop
hypoglycaemia after fundoplication [6]. The patient has had
undergone gastrectomy with Roux-en-Y anastomosis in 2003
and the operation was expanded to total gastrectomy
because of incidental finding of gastric polyps. The histology
was found to be benign. Diabetic autonomic and sensory
neuropathy, manifested by feet numbness and colonic dysmo-
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tility (bowel movement every 2 weeks) for which total
colectomy was contemplated; hyperlipidaemia, treated with
atorvastatin; epilepsy; bipolar disorder; sleep apnoea syn-
drome; asthma; benign prostatic hypertrophy; osteoarthritis;
asbestosis; and urolithiasis and the patient had previously
undergone cholecystectomy. The patient did not consume
alcohol. None of his medications were expected to alter his
carbohydrate metabolism. His physical examination was
normal except for temporal wasting (weight 88 kg, height
175 cm, BMI 29 kg/m2). The patient’s blood count, bio-
chemical profile, thyroid functions, lipase and amylase were
normal.
The results of two fasting studies, administered 3 months
apart, showed endogenous insulin-dependent hypoglycaemia.
In the first test, the patient developed symptomatic hypo-
glycaemia at 3.3 mmol/l (60 mg/dl) after a 48-h fast, while
plasma insulin and C-peptide levels were 64.2 pmol/l (10.7
mcu/ml) and 0.6 nmol/l (1.7 ng/ml), respectively. During the
second fasting test, the patient developed hypoglycaemia at
2 mmol/l (36 mg/dl) after a 4-h fast, while plasma insulin,
proinsulin and C-peptide levels were 46.8 pmol/l (7.8 mcu/
ml), 9.7 pmol/l and 0.4 nmol/l (1.3 ng/ml), respectively.
Abnormal was defined as insulin level ≥ 36 pmol/l (≥ 6 mcu/
ml), proinsulin level ≥ 5 pmol/l and C-peptide level or
≥ 0.2 nmol/l (≥ 0.6 ng/ml) [7]. Blood screens for oral hypo-
glycaemic agents were negative. Transoesophageal ultraso-
nography did not show pancreatic lesions. Abdominal
magnetic resonance imaging showed a 6-mm con-
trast-enhancing lesion in the pancreatic head and a few
5-mm foci in the liver. Both lesions were found to be stable in
periodic imaging. A 111-indium octreotide scan was negative.
The results of selective intra-arterial calcium stimulation with
hepatic venous sampling are shown in Fig. 1. The test showed
a 2–3-fold rise in plasma insulin and a 1.3–2-fold rise in
plasma C-peptide levels, after calcium stimulation of the
splenic, gastroduodenal, common hepatic and superior mes-
enteric arteries with a peak detected after 60 s. Injection of
calcium to the proper hepatic artery (control) did not change
insulin and C-peptide levels in the hepatic vein. The test was
interpreted as abnormal with mild oversecretion of insulin
from the entire pancreas.
The complete clinical picture was felt to be consistent with
non-insulinoma pancreatogenous hypoglycaemia, secondary
to Roux-en-Y anastomosis. In January 2007, the patient
underwent total colectomy and ileosigmoid anastomosis (to
alleviate his chronic constipation), distal pancreatectomy
(50% of the pancreas) to alleviate his hypoglycaemia [3] and
splenectomy. The pancreas was dissected adjacent to the
superior mesenteric vein. In gross pathology the cut surface
of the pancreas was not found to harbour tumours. Histo-
pathology was taken from multiple locations and identified
pancreatitis with a corresponding loss of exocrine pancreatic
tissue and islet retention (Fig. 2a), amyloid deposition within
pancreatic islets (Fig. 2b) and incidental low-grade dysplasia
of ductal epithelium. Distributions of b and a cells were
normal (Fig. 2c and 2d).
Less than 1 month after the operation the patient’s
hypoglycaemia relapsed with glucose readings of 2.5–
3.3 mmol/l (45–60 mg/dl). Yet, in contrast to the pre-surgery
period, his hypoglycaemia had been successfully controlled
[readings > 3.3 mmol/L (> 60 mg/dl)] with a combination of
diazoxide 150–200 mg 3–4 times per day and lanreotide
80 mg every 4 weeks (similar to his pre-surgery doses).
Discussion
The presented patient exhibits an atypical case of post-gastric
bypass hyperinsulinaemic hypoglycaemia. Although previous
reports have mainly described postprandial symptoms, some
have described severe cases of neuroglycopenia that occurred
also before meals or required continuous glucose infusion
[8]. In these cases, the differentiation betweenpreprandial
and postprandial periods is vague. Moreover, excessive
glucagon-like peptide 1 secretion has been implicated in this
condition [1–3] and shown to occur both before and after
meals [9]. It is not improbable that the patient may have
developed delayed postprandial hypoglycaemia as a result of
gastrointestinal dysmotility. Evidently, during his second
fasting test, hypoglycaemia occurred 4 h after eating. Several
clinical details clearly support the relevance of our report to
the post-gastric bypass state. As expected, hypoglycaemia
started a few years after the gastric bypass [3], a fasting test
identified endogenous hyperinsulinaemia, selective arterial
calcium stimulation showed generalized pancreatic hyperin-
sulinaemia and cross-sectional studies and pathological
examination did not identify insulinoma.
Instead of an abundance of b-cell mass as expected in this
setting [3], pancreatic histology showed chronic pancreatitis
and pancreatic islets amyloidosis. Both histological findings
and their corresponding medical conditions are expected to
cause insulin deficiency and hyperglycaemia. While a
number of groups have reported an abundance of pancrea-
tic islets and periductal beta-cell budding compared to
controls [3] other groups have failed to substantiate these
findings [10].
Amyloid deposition in pancreatic islets, derived from
islet amyloid polypeptide or amylin is traditionally impli-
cated with longstanding Type 2 diabetes [11] and, to the
best of our knowledge, has not been described after diabetes
What’s new?
• We present a case of a patient with post Roux-en-Y
hypoglycaemia and pancreatic histology typically asso-
ciated with diabetes.
• We show that hyperinsulinaemic hypoglycaemia has a
multifactorial aetiology.
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remission. These deposits have been detected also in patients
with insulinoma [12,13]. In these cases amylin is probably
over- synthesized alongside insulin and ultimately forms
amyloid tufts. Recurrent hypoglycaemia and brittle diabetes
pattern is seen in patients treated with insulin for pancrea-
titis-associated diabetes and these have been explained by
glucagon deficiency and maldigestion [14].
We hypothesize that the patient in the present report may
have developed recurrent hypoglycaemia as a result of
hyperinsulinaemia (evidenced by his biochemical profile
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FIGURE 1 Selective intra-arterial calcium stimulation with hepatic venous sampling (as previously described [15]). a) Insulin. b) C-peptide.
Intravascular catheters were inserted via the femoral artery and femoral vein.
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FIGURE 2 Representative histopathology of pancreatic tissue. a) Chronic pancreatitis with loss of exocrine tissue and collapse of lobule architecture.
Remnant acinar tissue (black arrows) and islets of Langerhans (black arrowheads) are surrounded by connective tissue with minimal lymphocytes.
Haematoxylin and eosin-stained pancreatic section. b) Representative islet of Langerhans with amyloid deposition. Amyloid tufts (red arrows)
are embedded between endocrine cells. Haematoxylin and eosin-stained pancreatic section. c) Insulin immunohistochemistry. Representative
pancreatic islet with amyloid deposition. b cells (arrows) comprise the majority of the endocrine cells in a typical distribution. d) Glucagon
immunohistochemistry. Representative pancreatic islet showing a cells (arrows) in a typical frequency and distribution.
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and islets amyloid), potentially combined with glucagon
deficiency and carbohydrate maldigestion (resulting from
chronic pancreatitis). Pancreatitis may not have inflicted pain
owing to autonomic neuropathy. It is possible that undergo-
ing total gastrectomy during his gastric bypass had exposed
him to a shortened food passage and thus made absorption
even more difficult. Partial pancreatectomy may have allevi-
ated his hypoglycaemia but not cured it, as the surgical
procedure decreased b-cell mass but would not have
improved glucagon deficiency or carbohydrate maldigestion.
Additional metabolic insults (e.g. chronic pancreatitis, mal-
absorption, dumping syndrome) may be needed to tip the
balance of a patient’s homeostasis toward hypoglycaemia.
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